Get The Policy Briefings Newsletter
Get into the weeds on hot policy issues and the players shaping them.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
FOLLOW THE HILL TIMES:
Want to make sure your whole office has the full Hill Times experience?
We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.
More Opinion
Related Stories
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need new drugs either have their access long delayed, or denied.
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need new drugs either have their access long delayed, or denied.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
- Politics
- Foreign Policy
- Lobbying
- Legislation
- Policy Briefings
- Politics This Morning
- Hill Climbers
- Civil Circles
- Heard On The Hill
- Election
- Finance and Budget
- Public Service
- Exclusive Lists
- Parliamentary Calendar
- Top 100 Lists and Exclusive Features
- Podcasts
- This Week's Paper
- Search
- Archives
- Digital Newspaper Archives
-
Get free news updates